Call Options Transactions Made in Q4 2023 in Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO) during Q4 2023. The information is specifically focused on institutions that hold call options of AGIOS PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
CALL |
60KNew |
$1.2M - $1.47M
|
60K
$3.34M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
19.9K+ 30.15% |
$397K - $488K
|
85.9K
$4.78M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-4K- 26.32% |
$79.9K - $98.1K
|
11.2K
$624K
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-6K- 54.05% |
$120K - $147K
|
5.1K
$284K
|
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
SELL
|
CALL |
-29.9K- 50.94% |
$597K - $733K
|
28.8K
$1.6M
|